Follow
Andrew K H Robertson
Andrew K H Robertson
Verified email at bccancer.bc.ca
Title
Cited by
Cited by
Year
An eighteen‐membered macrocyclic ligand for actinium‐225 targeted alpha therapy
NA Thiele, V Brown, JM Kelly, A Amor‐Coarasa, U Jermilova, ...
Angewandte Chemie International Edition 56 (46), 14712-14717, 2017
2062017
Development of 225Ac radiopharmaceuticals: TRIUMF perspectives and experiences
AKH Robertson, CF Ramogida, P Schaffer, V Radchenko
Current radiopharmaceuticals 11 (3), 156-172, 2018
1482018
232Th-Spallation-Produced 225Ac with Reduced 227Ac Content
AKH Robertson, BL McNeil, H Yang, D Gendron, R Perron, V Radchenko, ...
Inorganic Chemistry 59 (17), 12156-12165, 2020
612020
225Ac-H4py4pa for Targeted Alpha Therapy
L Li, J Rousseau, MDG Jaraquemada-Pelaez, X Wang, A Robertson, ...
Bioconjugate Chemistry 32 (7), 1348-1363, 2020
562020
Multi-isotope SPECT imaging of the 225Ac decay chain: feasibility studies
AKH Robertson, CF Ramogida, C Rodriguez-Rodriguez, S Blinder, ...
Physics in Medicine & Biology 62 (11), 4406, 2017
562017
Production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair
BL McNeil, AKH Robertson, W Fu, H Yang, C Hoehr, CF Ramogida, ...
EJNMMI radiopharmacy and chemistry 6, 1-18, 2021
552021
Synthesis and Evaluation of a Macrocyclic Actinium‐225 Chelator, Quality Control and In Vivo Evaluation of 225Ac‐crown‐αMSH Peptide
H Yang, C Zhang, Z Yuan, C Rodriguez‐Rodriguez, A Robertson, ...
Chemistry–A European Journal 26 (50), 11435-11440, 2020
512020
Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced 225 Ac
CF Ramogida, AKH Robertson, U Jermilova, C Zhang, H Yang, P Kunz, ...
EJNMMI Radiopharmacy and Chemistry 4, 1-20, 2019
502019
Medical isotope production at TRIUMF–from imaging to treatment
C Hoehr, F Bénard, K Buckley, J Crawford, A Gottberg, V Hanemaayer, ...
Physics Procedia 90, 200-208, 2017
482017
Design of a Thorium Metal Target for 225Ac Production at TRIUMF
AKH Robertson, A Lobbezoo, L Moskven, P Schaffer, C Hoehr
Instruments 3 (1), 18, 2019
212019
CT image artifacts from brachytherapy seed implants: a postprocessing 3D adaptive median filter
PS Basran, A Robertson, D Wells
Medical Physics 38 (2), 712-718, 2011
182011
Evaluation of 209At as a theranostic isotope for 209At-radiopharmaceutical development using high-energy SPECT
JR Crawford, AKH Robertson, H Yang, C Rodríguez-Rodríguez, ...
Physics in Medicine & Biology 63 (4), 045025, 2018
162018
CT, MR, and ultrasound image artifacts from prostate brachytherapy seed implants: the impact of seed size
AKH Robertson, PS Basran, SD Thomas, D Wells
Medical Physics 39 (4), 2061-2068, 2012
162012
Design and simulation of a thorium target for 225Ac production
AKH Robertson, K Ladouceur, M Nozar, L Moskven, CF Ramogida, ...
AIP Conference Proceedings 1845 (1), 2017
102017
Medical isotope collection from ISAC targets
P Kunz, C Andreoiu, V Brown, M Cervantes, J Even, FH Garcia, ...
EPJ Web of Conferences 229, 06003, 2020
72020
Ac-225 Production using TRIUMF’s 500 MeV Cyclotron
A Robertson, C Hoehr, A Lobbezoo, L Moskven, V Radchenko, H Yang, ...
Journal of Medical Imaging and Radiation Sciences 50 (1), S18, 2019
72019
Nuclide production cross sections from irradiation of thorium by 438 MeV protons and a comparison to fluka and geant4 simulations
AKH Robertson, P Kunz, C Hoehr, P Schaffer
Physical Review C 102 (4), 044613, 2020
62020
A novel actinium bifunctional chelator Crown and biodistribution of Ac-225-Crown-TATE
H Yang, F Gao, Z Yuan, C Rodriguez-Rodriguez, H Merkens, A Robertson, ...
Journal of Nuclear Medicine 61 (supplement 1), 1235-1235, 2020
52020
Medical isotopes from ISAC actinide targets
P Kunz, C Andreoiu, JR Crawford, J Even, FH Garcia, L Lambert, ...
Progress in Nuclear Science and Technology 5, 4-7, 2018
52018
Systems, apparatus and methods for separating actinium, radium, and thorium
AKH Robertson, H Yang, S Zeisler, P Schaffer
US Patent 11,798,700, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20